Abstract:Background: Aging is related to an increased risk of morbidity and mortality and is affected by environmental factors. Exposure to polycyclic aromatic hydrocarbons (PAHs) is associated with adverse health outcomes; but the association of such exposure with DNA methylation aging, a novel aging marker, is unclear. Objectives: Our aim was to investigate the association of PAH exposure with methylation aging. Methods: We trained and validated a methylation age predictor suitable for Chinese populations using whole blood methylation data in 989 Chinese and 160 Caucasians. We defined two aging indicators: Δage, as methylation age minus chronological age; and aging rate, the ratio of methylation to chronological age. The association of PAH exposure with aging indicators was evaluated using linear regressions in three panels of healthy Chinese participants (N=539, among the aforementioned 989 Chinese participants) whose exposure levels were assessed by 10 urinary monohydroxy-PAH metabolites. Results: We developed a methylation age predictor providing accurate predictions in both Chinese individuals and Caucasian persons (R=0.94–0.96, RMSE=3.8–4.3). Among the 10 urinary metabolites that we measured, 1-hydroxypyrene and 9-hydroxyphenanthrene were associated with methylation aging independently of other OH-PAHs and risk factors; 1-unit increase in 1-hydroxypyrene was associated with a 0.53-y increase in Δage [95% confidence interval (CI): 0.18, 0.88; false discovery rate (FDR) FDR=0.004] and 1.17% increase in aging rate (95% CI: 0.36, 1.98; FDR=0.02), whereas for 9-hydroxyphenanthrene, the increase was 0.54-y for Δage (95% CI: 0.17, 0.91; FDR=0.004), and 1.15% for aging rate (95% CI: 0.31, 1.99; FDR=0.02). The association direction was consistent across the three Chinese panels with the association magnitude correlating with the panels’ exposure levels; the association was validated by methylation data of purified leukocytes. Several cytosine-phosphoguanines, including those located on FHL2 and ELOVL2, were found associated with both aging indicators and monohydroxy-PAH levels. Conclusions: We developed a methylation age predictor specific for Chinese populations but also accurate for Caucasian populations. Our findings suggest that exposure to PAHs may be associated with an adverse impact on human aging and epigenetic alterations in Chinese populations. https://doi.org/10.1289/EHP2773

Promoter methylation analysis of SIRT3, SMARCA5, HTERT and CDH1 genes in aging and Alzheimer's disease

A Serum Mirna Profile of Human Longevity: Findings from the Baltimore Longitudinal Study of Aging (BLSA)

APOE Genotype-specific Methylation Patterns are Linked to Alzheimer Disease Pathology and Estrogen Response

Utility of DNA Methylation as a Biomarker in Aging and Alzheimer's Disease

Regional differences in gene expression and promoter usage in aged human brains

Promoter DNA Hypermethylation - Implications for Alzheimer's Disease

Genome-wide association studies identify 137 loci for DNA methylation biomarkers of ageing

Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging

Epigenome-wide DNA methylation analysis of late-stage mild cognitive impairment

DNA Methylation-Based Estimator of Telomere Length

Socioeconomic position, lifestyle habits and biomarkers of epigenetic aging: a multi-cohort analysis

Serotonin transporter gene promoter methylation in peripheral cells in healthy adults: Neural correlates and tissue specificity

DNA methylation in genes of longevity-regulating pathways: association with obesity and metabolic complications

Mirna Processing Gene Polymorphisms, Blood DNA Methylation Age and Long-Term Ambient PM2.5 Exposure in Elderly Men.

Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: a pooled analysis of four prospective studies

Exposure to Polycyclic Aromatic Hydrocarbons and Accelerated DNA Methylation Ageing: an Observational Study

Blood DNA methylation levels of the oxytocin promoter predict conversion from mild cognitive impairment to dementia in females within a clinical cohort of cognitive complaints

Dysregulation of the epigenetic landscape of normal aging in Alzheimer’s disease

EPIGENETIC PROFILES OF ALZHEIMER’S DISEASE

Epigenome-Wide Scans Identify Differentially Methylated Regions for Age and Age-Related Phenotypes in A Healthy Ageing Population

Complex Regulation of Protocadherin Epigenetics on Aging-Related Brain Health